Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CARRECA, Ignazio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.306
EU - Europa 1.408
AS - Asia 968
SA - Sud America 151
AF - Africa 14
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.285
CN - Cina 367
SG - Singapore 328
IT - Italia 304
UA - Ucraina 227
DE - Germania 222
BR - Brasile 126
FI - Finlandia 124
RU - Federazione Russa 116
HK - Hong Kong 95
PL - Polonia 84
GB - Regno Unito 72
IE - Irlanda 67
FR - Francia 53
SE - Svezia 49
KR - Corea 34
IN - India 30
VN - Vietnam 29
RO - Romania 23
BE - Belgio 14
NL - Olanda 14
TR - Turchia 14
MX - Messico 10
AT - Austria 9
TH - Thailandia 9
ES - Italia 8
AR - Argentina 7
BD - Bangladesh 7
IQ - Iraq 7
CA - Canada 6
CH - Svizzera 6
VE - Venezuela 6
AM - Armenia 5
UY - Uruguay 5
GR - Grecia 4
ID - Indonesia 4
IR - Iran 4
MY - Malesia 4
SA - Arabia Saudita 4
TW - Taiwan 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
JP - Giappone 3
LU - Lussemburgo 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
GH - Ghana 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.851
Salva come PNG Salva come JPEG
Città #
Ashburn 297
Fairfield 252
Singapore 170
Chandler 168
Woodbridge 154
Wilmington 132
Ann Arbor 117
Jacksonville 116
Houston 110
Seattle 98
Hong Kong 93
Cambridge 80
Dublin 67
Medford 61
Hefei 55
Des Moines 52
Nanjing 50
Beijing 47
Palermo 46
Kraków 40
Zgierz 40
Princeton 39
Moscow 38
Altamura 37
Tulsa 34
Boardman 33
Dearborn 25
Buffalo 24
Ludwigshafen am Rhein 22
Munich 22
Lawrence 21
Kitzingen 20
Los Angeles 20
Seoul 20
Nanchang 17
San Diego 17
Dallas 16
Milan 16
Shenyang 16
Ho Chi Minh City 14
São Paulo 14
Changsha 13
New York 13
Saint Petersburg 13
Brussels 12
Seongnam 12
Tianjin 12
Verona 12
Nuremberg 11
Guangzhou 10
Hebei 9
London 9
Santa Clara 9
Columbus 8
Rome 8
Belo Horizonte 7
Jiaxing 7
Turku 7
San Mateo 6
Auburn Hills 5
Chicago 5
Istanbul 5
Montevideo 5
Naples 5
Rio de Janeiro 5
San Francisco 5
Taizhou 5
Yerevan 5
Brooklyn 4
Council Bluffs 4
Denver 4
Düsseldorf 4
Hanoi 4
Kunming 4
Ningbo 4
Nürnberg 4
Orem 4
Abidjan 3
Acquedolci 3
Bolzano 3
Brasília 3
Cernusco sul Naviglio 3
Changchun 3
Chennai 3
Frankfurt am Main 3
Guarulhos 3
Hangzhou 3
Jinan 3
Kumar 3
Kyiv 3
Luxembourg 3
Messina 3
Riyadh 3
Shanghai 3
Sterling 3
Stockholm 3
Sunderland 3
The Dalles 3
Zhengzhou 3
Accra 2
Totale 3.037
Salva come PNG Salva come JPEG
Nome #
Founder mutations in BRCA1 and BRCA2 genes 247
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 233
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 220
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 215
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 205
Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study 189
Randomized Multicenter Phase II Trial of Two Different Schedules of Irinotecan Combined with Capecitabine as First-Line Treatment in Metastatic Colorectal Carcinoma 187
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 160
Cancer in the older person 158
Reticulocytes can represent an early indicator of erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy 149
Cancer chemotherapy in the older cancer patient 147
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 134
Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG) 133
Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis. 128
1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report 128
Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer A SICOG Phase II Study 124
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O). 123
EMATOPOIESI E INVECCHIAMENTO 118
Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC) 108
Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect? 108
Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial. 107
Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people. 103
Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings 102
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer 101
Myelotoxicity from cytostatic treatment, an important risk factor in the management of neoplasias in the elderly 100
Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring 97
Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients 94
FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE. 94
Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy. 90
Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer 88
VEGF and Chromogranin A (CgA): Possible new predictive factors in management of advanced prostatic cancer (APC) in elderly patients 86
VEGF values as a predictive factor of treatment efficiency in elderly women with advanced breast cancer 82
Sex and Gender in Ageing and Longevity: Highlights from an International Course 80
Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation. 79
SAFETY AND EFFICACY OF INHALED IL-2 THERAPY IN PRE-TREATED BREAST CANCER ELDERLY PATIENTS WITH PULMONARY METASTASES. 74
Oncogeriatry: Communication, sharing, coordination of an emerging reality. The IIIrd Official Meeting of the AIOM Working Group on Oncogeriatry 74
Non-Pegylated Liposomal Doxorubicin/Cyclophosphamide-based schedule As Antiangiogenic Treatment In Elderly Women With Advanced Breast Cancer 70
Safety and efficacy of two different schedules of capecitabine combined with oxaliplatin in the treatment of colon cancer in the elderly 70
VEGF levels could affect outcomes in elderly breast cancer women 61
Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome. 58
Totale 4.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021302 0 0 0 0 0 5 48 24 51 61 43 70
2021/2022376 20 95 7 9 9 17 14 17 47 51 22 68
2022/2023531 71 93 0 38 86 79 45 37 51 1 24 6
2023/2024256 13 39 9 10 17 27 26 54 10 6 10 35
2024/2025626 6 34 37 75 14 25 60 52 37 60 66 160
2025/2026830 184 78 146 151 159 112 0 0 0 0 0 0
Totale 4.924